Tesu Health, founded in 2022, is an innovative player in the digital health space, offering an evidence-based digital therapeutics platform dedicated to the personalized management of chronic diseases. This Cambridge Science Park-based startup is strategically positioned for global expansion, building on a strong foundation of expertise spanning software engineering, clinical medicine, pharmaceuticals, and private health insurance.
With a focus on robust research and development paired with strategic sales and marketing efforts, Tesu Health aims to ascend as a leading global entity in the digital therapeutics domain. The company's comprehensive business plan, encompassing meticulous market analysis and financial projections, underscores its commitment to fostering positive outcomes for investors and stakeholders alike.
After securing its latest funding through an angel investment on 01 November 2023, Tesu Health stands ready to leverage its fusion of technology and clinical acumen to revolutionize chronic disease treatment paradigms.